ArticleCell death & disease2025

Atypical cadherin CELSR2 acts as a therapeutic target for glioma through WNT3A/β-catenin signaling.

Aimei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.